Literature DB >> 22143677

Combined photodynamic therapy with verteporfin and intravitreal anti-vascular endothelial growth factor therapy for chronic central serous chorioretinopathy.

J Fernando Arevalo, Juan V Espinoza.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22143677     DOI： 10.1007/s00417-011-1884-5

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN： 0721-832X            Impact factor:   3.117


× No keyword cloud information.
  6 in total

1.  Half dose verteporfin PDT for central serous chorioretinopathy.

Authors:  J M Stewart
Journal:  Br J Ophthalmol       Date:  2006-07       Impact factor: 4.638

2.  Effect of photodynamic therapy alone or combined with posterior subtenon triamcinolone acetonide or intravitreal bevacizumab on choroidal hypofluorescence by indocyanine green angiography.

Authors:  Yoshiyuki Hatta; Kohei Ishikawa; Hiroaki Nishihara; Shinsuke Ozawa; Yasuki Ito; Hiroko Terasaki
Journal:  Retina       Date:  2010-03       Impact factor: 4.256

3.  Comparison of efficacy and safety between half-fluence and full-fluence photodynamic therapy for chronic central serous chorioretinopathy.

Authors:  Joo Young Shin; Se Joon Woo; Hyeong Gon Yu; Kyu Hyung Park
Journal:  Retina       Date:  2011-01       Impact factor: 4.256

4.  Severe choroidal ischemia following photodynamic therapy for pigment epithelial detachment and chronic central serous chorioretinopathy.

Authors:  Phil Young Lee; Ki Seok Kim; Won Ki Lee
Journal:  Jpn J Ophthalmol       Date:  2009-01-30       Impact factor: 2.447

5.  Half-dose verteporfin photodynamic therapy for acute central serous chorioretinopathy: one-year results of a randomized controlled trial.

Authors:  Wai-Man Chan; Timothy Y Y Lai; Ricky Y K Lai; David T L Liu; Dennis S C Lam
Journal:  Ophthalmology       Date:  2008-06-05       Impact factor: 12.079

6.  Standard-fluence versus low-fluence photodynamic therapy in chronic central serous chorioretinopathy: a nonrandomized clinical trial.

Authors:  Michele Reibaldi; Nicola Cardascia; Antonio Longo; Claudio Furino; Teresio Avitabile; Salvatore Faro; Marisa Sanfilippo; Andrea Russo; Maurizio Giacinto Uva; Ferdinando Munno; Vincenzo Cannemi; Marco Zagari; Francesco Boscia
Journal:  Am J Ophthalmol       Date:  2009-11-06       Impact factor: 5.258
  6 in total
  2 in total

Review 1.  Interventions for central serous chorioretinopathy: a network meta-analysis.

Authors:  Mahsa Salehi; Adam S Wenick; Hua Andrew Law; Jennifer R Evans; Peter Gehlbach
Journal:  Cochrane Database Syst Rev       Date:  2015-12-22

2.  Alternating central serous chorioretinopathy in two consecutive pregnancies.

Authors:  Abdullah Al-Mujaini; Upender Wali
Journal:  Oman J Ophthalmol       Date:  2014-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.